nv glucosamine 200 injection
ceva animal health pty ltd - glucosamine hydrochloride - parenteral liquid/solution/suspension - glucosamine hydrochloride carbohydrate-glucose active 200.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - improve joint function
nature's answer glucosamine tablets nature's answer
mavlab pty. ltd. - glucosamine hydrochloride - oral tablet - glucosamine hydrochloride carbohydrate-glucose active 500.0 mg/tb - musculoskeletal system - dog | bitch | castrate | puppy - inflammatory joint disease | non-infectious joint disease
glucose injection (baxter)
baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.
glucose injection (baxter)
baxter healthcare ltd - glucose monohydrate 25% - solution for infusion - 25 % - active: glucose monohydrate 25% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.
glucose injection (baxter)
baxter healthcare ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.
glucose injection (baxter)
baxter healthcare ltd - glucose monohydrate 70% - solution for infusion - 70 % - active: glucose monohydrate 70% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.
glucose
baxter healthcare limited - glucose monohydrate - solution for infusion - 10 %w/v - carbohydrates
glucose
fresenius kabi limited - glucose anhydrous - solution for infusion - 10 %w/w - carbohydrates
glucose 5% w/v solution for infusion
fresenius kabi limited - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates
glucose
maco pharma (uk) ltd - glucose monohydrate - solution for infusion - 5 %w/v - electrolytes with carbohydrates